Dr. Melissa Bonner Ph.D.
Vice President, Research, bluebird bio
Melissa Bonner, PhD is Vice President of Severe Genetic Disease Research at bluebird bio where she oversees translational gene therapy projects across the portfolio. Prior to joining bluebird bio in 2014, she was at St. Jude Children's Research Hospital for her postdoctoral training in the laboratory of the late Dr. Brian Sorrentino working on HSC expansion and next-generation virus production for gene therapy applications.